Vascular restenosis reduction with platelet membrane coated nanoparticle directed M2 macrophage polarization
Open Access
- 16 September 2022
- Vol. 25 (10) , 105147
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81970417)
This publication has 53 references indexed in Scilit:
- Restenosis after PCI. Part 1: pathophysiology and risk factorsNature Reviews Cardiology, 2011
- Platelet–Leukocyte Interactions in Cardiovascular Disease and BeyondArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Autocrine expression of osteopontin contributes to PDGF-mediated arterial smooth muscle cell migrationCardiovascular Research, 2007
- Regulation and characteristics of vascular smooth muscle cell phenotypic diversityNetherlands Heart Journal, 2007
- Platelet binding and phagocytosis by macrophagesTransfusion, 2006
- Leukocyte Engagement of Platelet Glycoprotein Ibα via the Integrin Mac-1 Is Critical for the Biological Response to Vascular InjuryCirculation, 2005
- Interleukin-10 Therapy—Review of a New ApproachPharmacological Reviews, 2003
- Platelet CD40 ligand (CD40L) – subcellular localization, regulation of expression, and inhibition by clopidogrelPlatelets, 2001
- Platelets and restenosisJACC, 2000
- Immunosuppressive and Anti-inflammatory Properties of Interleukin 10Annals of Medicine, 1995